Blue Jet Healthcare Share Price
Sector:
711.90 -11.00 (-1.52%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
708.10
Today’s High
729.40
52 Week Low
346.70
52 Week High
968.75
710.30 -12.75 (-1.76%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
705
Today’s High
732
52 Week Low
347.60
52 Week High
968.30
Key Metrics
- Market Cap (In Cr) 12397.03
- Beta -
- Div. Yield (%) 0.14
- P/B 14.84
- TTM P/E 41.72
- Peg Ratio 8.29
- Sector P/E 26.62
- Open Price 721.95
- Prev Close 722.9
Blue Jet Healthcare Analysis
Price Analysis
-
1 Week-5.14%
-
3 Months24.05%
-
6 Month53.06%
-
YTD28.04%
-
1 Year84.57%
Risk Meter
- 57% Low risk
- 57% Moderate risk
- 57% Balanced Risk
- 57% High risk
- 57% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 1
- Buy
- 2
- 2
- 2
- 1
- Hold
- 1
- 1
- 1
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 5
- 5
- 5
- 3
Blue Jet Healthcare News
Macquarie initiates outperform rating on 4 pharma stocks, sees 19-35% upside
2 min read . 20 Feb 2025These five stocks have rallied up to 70% during the smids bloodbath
6 min read . 18 Feb 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends 5 shares to buy today
2 min read . 24 Jan 2025Buy or sell: Vaishali Parekh recommends three intraday stocks for today — Nov 19
1 min read . 19 Nov 2024Blue Jet Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 711.6
- Selling/ General/ Admin Expenses Total
- 138.68
- Depreciation/ Amortization
- 28.09
- Other Operating Expenses Total
- 16.95
- Total Operating Expense
- 518.81
- Operating Income
- 192.79
- Net Income Before Taxes
- 220.09
- Net Income
- 163.75
- Diluted Normalized EPS
- 9.9
- Period
- 2024
- Total Assets
- 1058.85
- Total Liabilities
- 213.62
- Total Equity
- 845.22
- Tangible Book Valueper Share Common Eq
- 48.71
- Period
- 2024
- Cashfrom Operating Activities
- 241.26
- Cashfrom Investing Activities
- -263.76
- Cashfrom Financing Activities
- -1.99
- Net Changein Cash
- -24.48
- Period
- 2023
- Total Revenue
- 720.98
- Selling/ General/ Admin Expenses Total
- 136.37
- Depreciation/ Amortization
- 25.07
- Other Operating Expenses Total
- 13.05
- Total Operating Expense
- 526.97
- Operating Income
- 194.01
- Net Income Before Taxes
- 216.61
- Net Income
- 160.03
- Diluted Normalized EPS
- 9.22
- Period
- 2023
- Total Assets
- 862.06
- Total Liabilities
- 180.58
- Total Equity
- 681.49
- Tangible Book Valueper Share Common Eq
- 39.28
- Period
- 2023
- Cashfrom Operating Activities
- 141.56
- Cashfrom Investing Activities
- -147.25
- Cashfrom Financing Activities
- -4.24
- Net Changein Cash
- -9.93
- Period
- 2022
- Total Revenue
- 683.47
- Selling/ General/ Admin Expenses Total
- 123.58
- Depreciation/ Amortization
- 22.15
- Other Operating Expenses Total
- 10.78
- Total Operating Expense
- 456.35
- Operating Income
- 227.12
- Net Income Before Taxes
- 243.23
- Net Income
- 181.59
- Diluted Normalized EPS
- 10.47
- Period
- 2022
- Total Assets
- 713.38
- Total Liabilities
- 191.83
- Total Equity
- 521.54
- Tangible Book Valueper Share Common Eq
- 30.07
- Period
- 2022
- Cashfrom Operating Activities
- 146.42
- Cashfrom Investing Activities
- -76.03
- Cashfrom Financing Activities
- -56.15
- Net Changein Cash
- 14.25
- Period
- 2021
- Total Revenue
- 498.93
- Selling/ General/ Admin Expenses Total
- 109.36
- Depreciation/ Amortization
- 19.66
- Other Operating Expenses Total
- 7.74
- Total Operating Expense
- 317.85
- Operating Income
- 181.08
- Net Income Before Taxes
- 184.66
- Net Income
- 135.79
- Diluted Normalized EPS
- 8.05
- Period
- 2021
- Total Assets
- 536.27
- Total Liabilities
- 196.45
- Total Equity
- 339.82
- Tangible Book Valueper Share Common Eq
- 19.59
- Period
- 2021
- Cashfrom Operating Activities
- 129.28
- Cashfrom Investing Activities
- -50.73
- Cashfrom Financing Activities
- -27.49
- Net Changein Cash
- 51.06
- Period
- 2024-12-31
- Total Revenue
- 318.38
- Selling/ General/ Admin Expenses Total
- 14.83
- Depreciation/ Amortization
- 4.75
- Other Operating Expenses Total
- 35.12
- Total Operating Expense
- 199.11
- Operating Income
- 119.27
- Net Income Before Taxes
- 132.49
- Net Income
- 98.98
- Diluted Normalized EPS
- 5.71
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 208.26
- Selling/ General/ Admin Expenses Total
- 15.4
- Depreciation/ Amortization
- 4.62
- Other Operating Expenses Total
- 33.86
- Total Operating Expense
- 143.39
- Operating Income
- 64.87
- Net Income Before Taxes
- 76.92
- Net Income
- 58.35
- Diluted Normalized EPS
- 3.36
- Period
- 2024-09-30
- Total Assets
- 1181.03
- Total Liabilities
- 257.03
- Total Equity
- 924
- Tangible Book Valueper Share Common Eq
- 53.26
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 62.06
- Cashfrom Investing Activities
- -72.6
- Cashfrom Financing Activities
- -0.58
- Net Changein Cash
- -11.12
- Period
- 2024-06-30
- Total Revenue
- 162.9
- Selling/ General/ Admin Expenses Total
- 14.78
- Depreciation/ Amortization
- 3.48
- Other Operating Expenses Total
- 30.04
- Total Operating Expense
- 122.12
- Operating Income
- 40.78
- Net Income Before Taxes
- 49.47
- Net Income
- 37.78
- Diluted Normalized EPS
- 2.18
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 183.95
- Selling/ General/ Admin Expenses Total
- 43.5
- Depreciation/ Amortization
- 7.72
- Total Operating Expense
- 137.2
- Operating Income
- 46.74
- Net Income Before Taxes
- 54.15
- Net Income
- 39.65
- Diluted Normalized EPS
- 2.29
- Period
- 2024-03-31
- Total Assets
- 1058.85
- Total Liabilities
- 213.62
- Total Equity
- 845.22
- Tangible Book Valueper Share Common Eq
- 48.71
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 241.26
- Cashfrom Investing Activities
- -263.76
- Cashfrom Financing Activities
- -1.99
- Net Changein Cash
- -24.48
- Period
- 2023-12-31
- Total Revenue
- 166.76
- Selling/ General/ Admin Expenses Total
- 13.02
- Depreciation/ Amortization
- 7.85
- Other Operating Expenses Total
- 28.31
- Total Operating Expense
- 129.78
- Operating Income
- 36.98
- Net Income Before Taxes
- 43.7
- Net Income
- 32.11
- Diluted Normalized EPS
- 2.26
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 181.35
- Selling/ General/ Admin Expenses Total
- 13.31
- Depreciation/ Amortization
- 6.47
- Other Operating Expenses Total
- 27.1
- Total Operating Expense
- 125.2
- Operating Income
- 56.16
- Net Income Before Taxes
- 64.33
- Net Income
- 47.87
- Diluted Normalized EPS
- 2.76
- Period
- 2023-09-30
- Total Assets
- 963.52
- Total Liabilities
- 189.9
- Total Equity
- 773.63
- Tangible Book Valueper Share Common Eq
- 44.59
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 88.35
- Cashfrom Investing Activities
- -96.93
- Cashfrom Financing Activities
- -1.44
- Net Changein Cash
- -10.02
- Period
- 2023-06-30
- Total Revenue
- 179.54
- Selling/ General/ Admin Expenses Total
- 12.74
- Depreciation/ Amortization
- 6.05
- Other Operating Expenses Total
- 28.61
- Total Operating Expense
- 126.63
- Operating Income
- 52.91
- Net Income Before Taxes
- 57.92
- Net Income
- 44.12
- Diluted Normalized EPS
- 2.54
- Period
- 2023-06-30
- Total Assets
- 903.8
- Total Liabilities
- 178.12
- Total Equity
- 725.68
- Tangible Book Valueper Share Common Eq
- 41.83
- Period
- 2023-06-30
- Cashfrom Operating Activities
- 42.32
- Cashfrom Investing Activities
- -40.13
- Cashfrom Financing Activities
- -1
- Net Changein Cash
- 1.19
- Period
- 2023-03-31
- Total Revenue
- 720.98
- Selling/ General/ Admin Expenses Total
- 136.37
- Depreciation/ Amortization
- 25.07
- Other Operating Expenses Total
- 13.05
- Total Operating Expense
- 526.97
- Operating Income
- 194.01
- Net Income Before Taxes
- 216.61
- Net Income
- 160.03
- Diluted Normalized EPS
- 9.23
- Period
- 2023-03-31
- Total Assets
- 862.06
- Total Liabilities
- 180.58
- Total Equity
- 681.49
- Tangible Book Valueper Share Common Eq
- 39.28
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 141.56
- Cashfrom Investing Activities
- -147.25
- Cashfrom Financing Activities
- -4.24
- Net Changein Cash
- -9.93
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Blue Jet Healthcare Technical
Moving Average
SMA
- 5 Day744.59
- 10 Day728.47
- 20 Day763.01
- 50 Day794.03
- 100 Day689.17
- 300 Day586.76
Blue Jet Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Sai Life Sciences
- 678.7
- -10.3
- -1.49
- 808.2
- 635.3
- 14227.68
- Acme Solar Holdings
- 209.7
- -2.75
- -1.29
- 292
- 167.55
- 12688.69
- Blue Jet Healthcare
- 711.9
- -11
- -1.52
- 968.75
- 346.7
- 12397.03
- Cello World
- 560.8
- -2.85
- -0.51
- 1024.5
- 485.2
- 12421.39
- Sbfc Finance
- 105.86
- -0.14
- -0.13
- 109.9
- 77
- 11496.39
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Sai Life Sciences
- 172.74
- 14.67
- -
- -
- Acme Solar Holdings
- 83.7
- 4.96
- -
- -
- Blue Jet Healthcare
- 73.06
- 14.84
- -
- -
- Cello World
- 36.4
- 10.4
- -
- -
- Sbfc Finance
- 40.26
- 4.1
- -
- -
Blue Jet Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-Jan-25
- Quarterly Results
- 29-Oct-24
- Quarterly Results
- 06-Aug-24
- Quarterly Results
- 25-May-24
- Audited Results & Dividend
- 06-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 16-Feb-25
- 15-Jan-25
- POM
- -
- 07-Aug-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 27-May-24
- 18-Sept-24
- 18-Sept-24
- 1


